日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Optimizing uPAR-targeting radiopeptides for improved tissue distribution: progress towards radionuclide therapy

优化靶向 uPAR 的放射性肽以改善组织分布：放射性核素治疗的进展

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-025-07602-7
Vaccarin, Christian; Beyer, Darja; Schmid, Jerome V; Klein, Bastian; Jegathasan, Jathursa; Behera, Shreshtha; Deupi, Xavier; Schibli, Roger; Müller, Cristina
uPAR
uPA
发表日期：2026
文献求助 收藏

Development of lisinopril radioconjugates for nuclear imaging of the angiotensin converting enzyme

赖诺普利放射性偶联物在血管紧张素转换酶核成像中的应用研究

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-025-07386-w
Vaccarin, Christian; Beyer, Darja; Moiseeva, Anzhelika; Favaretto, Chiara; van der Meulen, Nicholas P; Hunkeler, Benjamin D; Rupp, Niels J; Marzaro, Giovanni; Schibli, Roger; Müller, Cristina
发表日期：2025
文献求助 收藏

Design and Preclinical Evaluation of Novel uPAR-Targeting Radiopeptides Modified with an Albumin-Binding Entity

利用白蛋白结合实体修饰的新型uPAR靶向放射性肽的设计和临床前评估

期刊:Molecular Pharmaceutics
影响因子:4.5
doi:10.1021/acs.molpharmaceut.5c00135
Beyer, Darja; Vaccarin, Christian; Schmid, Jerome V; Deberle, Luisa M; Deupi, Xavier; Schibli, Roger; Müller, Cristina
uPAR
uPA
发表日期：2025
文献求助 收藏

Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2

开发用于SARS-CoV-2进入受体ACE2 PET成像的放射性氟化MLN-4760衍生物

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-024-06831-6
Wang, Jinling; Beyer, Darja; Vaccarin, Christian; He, Yingfang; Tanriver, Matthias; Benoit, Roger; Deupi, Xavier; Mu, Linjing; Bode, Jeffrey W; Schibli, Roger; Müller, Cristina
SARS-CoV-2
信号转导
ACE2
发表日期：2024
文献求助 收藏

Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder.

设计和临床前评估一种新型前列腺特异性膜抗原放射性配体，该配体经转甲状腺素结合剂修饰

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16071262
Vaccarin Christian, Mapanao Ana Katrina, Deberle Luisa M, Becker Anna E, Borgna Francesca, Marzaro Giovanni, Schibli Roger, Müller Cristina
其它
发表日期：2024
文献求助 收藏

Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4'-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis

自乳化制剂可提高4,6,4'-三甲基白芷素的口服生物利用度，作为囊性纤维化的潜在治疗方法

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics14091806
Franceschinis, Erica; Roverso, Marco; Gabbia, Daniela; De Martin, Sara; Brusegan, Matteo; Vaccarin, Christian; Bogialli, Sara; Chilin, Adriana
发表日期：2022
文献求助 收藏

Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening

用于治疗囊性纤维化的改良型三甲基白芷素类似物：设计、合成和初步筛选

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms231911528
Vaccarin, Christian; Gabbia, Daniela; Franceschinis, Erica; De Martin, Sara; Roverso, Marco; Bogialli, Sara; Sacchetti, Gianni; Tupini, Chiara; Lampronti, Ilaria; Gambari, Roberto; Cabrini, Giulio; Dechecchi, Maria Cristina; Tamanini, Anna; Marzaro, Giovanni; Chilin, Adriana
发表日期：2022
文献求助 收藏

Elexacaftor co-potentiates the activity of F508del and gating mutants of CFTR

Elexacaftor 可增强 CFTR 的 F508del 突变体和门控突变体的活性。

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2021.03.011
Veit, Guido; Vaccarin, Christian; Lukacs, Gergely L
CFTR
发表日期：2021
文献求助 收藏